换一批
换一批A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment.
作者：
关键词
ACQ, Asthma Control QuestionnaireBID, twice dailyBenralizumabBiologicsEosinophiliaFEV1, forced expiratory volume in 1 secondFVC, forced vital capacityFeNO, fractional exhaled nitric oxideICS, inhaled corticosteroid(s)IL, interleukinIM, intramuscularIg, immunoglobulinLABA, long-acting β2-agonistOCS, oral corticosteroid(s)Q4W, every 4 weeksQ8W, every 8 weeksQD, once dailyQuality of lifeSAC, severe asthma centerSC, subcutaneouslySevere eosinophilic asthma
DOI
10.1016/j.rmcr.2021.101557
PMID
34877251
发布时间
2021-12-11
- 浏览0
Respiratory medicine case reports
2021年34卷
101557页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
